{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T16:09:49Z","timestamp":1764259789486,"version":"3.44.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.ajog.2012.04.029","type":"journal-article","created":{"date-parts":[[2012,4,30]],"date-time":"2012-04-30T21:36:29Z","timestamp":1335821789000},"page":"65.e1-65.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women"],"prefix":"10.1016","volume":"207","author":[{"given":"Brenna L.","family":"Anderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimi","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Raker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Fahey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dwight J.","family":"Rouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles R.","family":"Wira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Cu-Uvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2012.04.029_bib2","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1001\/jama.1991.03470120066034","article-title":"Female-to-male transmission of human immunodeficiency virus","volume":"266","author":"Padian","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2012.04.029_bib3","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/bmj.304.6830.809","article-title":"Comparison of female to male and male to female transmission of HIV in 563 stable couples","volume":"304","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2012.04.029_bib4","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(05)67481-8","article-title":"Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study","volume":"366","author":"Gray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2012.04.029_bib5","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/QAD.0b013e3280f00fc4","article-title":"Pregnancy and the risk of HIV-1 acquisition among women in Uganda and Zimbabwe","volume":"21","author":"Morrison","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.ajog.2012.04.029_bib6","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1097\/QAD.0b013e3282f155da","article-title":"Frequent detection of acute HIV infection in pregnant women","volume":"21","author":"Patterson","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.ajog.2012.04.029_bib7","first-page":"606","article-title":"Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women","volume":"53","author":"Reid","year":"2010","journal-title":"JAIDS"},{"key":"10.1016\/j.ajog.2012.04.029_bib8","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1177\/1933719109341998","article-title":"Elafin (SKALP\/Trappin-2\/proteinase inhibitor-3) is produced by the cervix in pregnancy and cervicovaginal levels are diminished in bacterial vaginosis","volume":"16","author":"Stock","year":"2009","journal-title":"Reprod Sci"},{"key":"10.1016\/j.ajog.2012.04.029_bib9","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1067\/mob.2000.107383","article-title":"Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections","volume":"183","author":"Draper","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.04.029_bib10","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/j.ajog.2004.07.010","article-title":"Genome-wide expression profiling of fetal membranes reveals a deficient expression of proteinase inhibitor 3 in premature rupture of membranes","volume":"191","author":"Tromp","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.04.029_bib11","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.virol.2008.02.007","article-title":"Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination","volume":"375","author":"Polonis","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.ajog.2012.04.029_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-0897.2009.00713.x","article-title":"CCL20\/MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tract","volume":"62","author":"Ghosh","year":"2009","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2012.04.029_bib13","doi-asserted-by":"crossref","first-page":"e8781","DOI":"10.1371\/journal.pone.0008781","article-title":"Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trials","volume":"5","author":"Keller","year":"2010","journal-title":"PLoS ONE [Electronic Resource]"},{"key":"10.1016\/j.ajog.2012.04.029_bib14","doi-asserted-by":"crossref","first-page":"11188","DOI":"10.1128\/JVI.00562-09","article-title":"Human uterine natural killer cells but not blood natural killer cells inhibit human immunodeficiency virus Type 1 infection by secretion of CXCL12","volume":"83","author":"Mselle","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.ajog.2012.04.029_bib15","doi-asserted-by":"crossref","first-page":"e11366","DOI":"10.1371\/journal.pone.0011366","article-title":"Anti-HIV Activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies","volume":"5","author":"Ghosh","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ajog.2012.04.029_bib16","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1600-0897.2010.00842.x","article-title":"Sex hormone regulation of innate immunity in the female reproductive tract: the role of epithelial cells in balancing reproductive potential with protection against sexually transmitted pathogens","volume":"63","author":"Wira","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2012.04.029_bib17","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","article-title":"Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women","volume":"329","author":"Abdool Karim","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ajog.2012.04.029_bib18","doi-asserted-by":"crossref","first-page":"F13","DOI":"10.1097\/QAD.0b013e3283522272","article-title":"How well does PREP work?","volume":"26","author":"van der Straten","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.ajog.2012.04.029_bib19","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1067\/S0002-9378(03)00518-0","article-title":"Decreased cervical proinflammatory cytokines permit subsequent upper genital tract infection during pregnancy","volume":"189","author":"Simhan","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.04.029_bib20","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1097\/QAD.0b013e3283060ea4","article-title":"A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle","volume":"22","author":"Wira","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.ajog.2012.04.029_bib21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.biochi.2007.09.007","article-title":"Multifaceted roles of human elafin and secretory leukocyte proteinase inhibitor (SLPI), two serine protease inhibitors of the chelonianin family","volume":"90","author":"Moreau","year":"2008","journal-title":"Biochimie"},{"key":"10.1016\/j.ajog.2012.04.029_bib22","first-page":"199","article-title":"Innate host defense of human vaginal and cervical mucosae","volume":"306","author":"Cole","year":"2006","journal-title":"Curr Topics Microbiol Immunol"},{"key":"10.1016\/j.ajog.2012.04.029_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0897.2007.00561.x","article-title":"Antimicrobial polypeptides are key anti-HIV-1 effector molecules of cervicovaginal host defense","volume":"59","author":"Cole","year":"2008","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2012.04.029_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-0897.2009.00713.x","article-title":"CCL20\/MIP3\u03b1 is a novel anti-HIV-1 molecule of the human female reproductive tract","volume":"62","author":"Ghosh","year":"2009","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.ajog.2012.04.029_bib25","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2567.2009.03165.x","article-title":"Trappin-2\/Elafin: a novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract","volume":"129","author":"Ghosh","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.ajog.2012.04.029_bib26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/QAD.0b013e328013d9b5","article-title":"PRO 2000 elicits a decline in genital tract immune mediators without compromising intrinsic antimicrobial activity","volume":"21","author":"Keller","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.ajog.2012.04.029_bib27","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1086\/521628","article-title":"Cytokines, pregnancy, and bacterial vaginosis: comparison of levels of cervical cytokines in pregnant and nonpregnant women with bacterial vaginosis","volume":"196","author":"Beigi","year":"2007","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajog.2012.04.029_bib28","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1067\/S0002-9378(03)00653-7","article-title":"Vaginal cytokines in normal pregnancy","volume":"189","author":"Donders","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2012.04.029_bib29","series-title":"Creasy & Resnik's maternal-fetal medicine","first-page":"87","article-title":"The immunology of pregnancy","author":"Mor","year":"2009"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937812004267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937812004267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:44:06Z","timestamp":1757587446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937812004267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0002937812004267"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2012.04.029","relation":{},"ISSN":["0002-9378"],"issn-type":[{"type":"print","value":"0002-9378"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro anti-HIV-1 activity in cervicovaginal secretions from pregnant and nonpregnant women","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2012.04.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}